Journal of Clinical Medicine (Jan 2022)

The Challenge of Converting “Failed Spinal Cord Stimulation Syndrome” Back to Clinical Success, Using SCS Reprogramming as Salvage Therapy, through Neurostimulation Adapters Combined with 3D-Computerized Pain Mapping Assessment: A Real Life Retrospective Study

  • Philippe Rigoard,
  • Amine Ounajim,
  • Lisa Goudman,
  • Tania Banor,
  • France Héroux,
  • Manuel Roulaud,
  • Etienne Babin,
  • Bénédicte Bouche,
  • Philippe Page,
  • Bertille Lorgeoux,
  • Sandrine Baron,
  • Nihel Adjali,
  • Kevin Nivole,
  • Mathilde Many,
  • Elodie Charrier,
  • Delphine Rannou,
  • Laure Poupin,
  • Chantal Wood,
  • Romain David,
  • Maarten Moens,
  • Maxime Billot

DOI
https://doi.org/10.3390/jcm11010272
Journal volume & issue
Vol. 11, no. 1
p. 272

Abstract

Read online

While paresthesia-based Spinal Cord Stimulation (SCS) has been proven effective as treatment for chronic neuropathic pain, its initial benefits may lead to the development of “Failed SCS Syndrome’ (FSCSS) defined as decrease over time related to Loss of Efficacy (LoE) with or without Loss of Coverage (LoC). Development of technologies associating new paresthesia-free stimulation waveforms and implanted pulse generator adapters provide opportunities to manage patients with LoE. The main goal of our study was to investigate salvage procedures, through neurostimulation adapters, in patients already implanted with SCS and experiencing LoE. We retrospectively analyzed a cohort of patients who were offered new SCS programs/waveforms through an implanted adapter between 2018 and 2021. Patients were evaluated before and at 1-, 3-, 6- and 12-month follow-ups. Outcomes included pain intensity rating with a Visual Analog Scale (VAS), pain/coverage mappings and stimulation preferences. Last follow-up evaluations (N = 27) showed significant improvement in VAS (p = 0.0001), ODI (p = 0.021) and quality of life (p = 0.023). In the 11/27 patients with LoC, SCS efficacy on pain intensity (36.89%) was accompanied via paresthesia coverage recovery (55.57%) and pain surface decrease (47.01%). At 12-month follow-up, 81.3% preferred to keep tonic stimulation in their waveform portfolio. SCS conversion using adapters appears promising as a salvage solution, with an emphasis on paresthesia recapturing enabled via spatial retargeting. In light of these results, adapters could be integrated in SCS rescue algorithms or should be considered in SCS rescue.

Keywords